Clinical Trials Browser

Phase 1/2 × elesclomol × Thoracic × Clear all

NCT00088088 2008-12-04

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung